Another interesting problem in severe COVID-19 patients stems from the fact that those individuals have marked lymphopenia, which, with the study that specifies a reduction of CD8+ T cells in the bloodstream with worse prognosis, suggests that the primary T cell activity is not located in the bloodstream but in the lungs instead (76–78). The gene discussed is CD8A; the disease is COVID-19.